PH31582A - Glycoslated cytokins. - Google Patents
Glycoslated cytokins.Info
- Publication number
- PH31582A PH31582A PH46943A PH46943A PH31582A PH 31582 A PH31582 A PH 31582A PH 46943 A PH46943 A PH 46943A PH 46943 A PH46943 A PH 46943A PH 31582 A PH31582 A PH 31582A
- Authority
- PH
- Philippines
- Prior art keywords
- glycoslated
- cytokins
- cytokine
- liver
- sugar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25496292 | 1992-09-24 | ||
JP8892093 | 1993-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31582A true PH31582A (en) | 1998-11-03 |
Family
ID=26430256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH46943A PH31582A (en) | 1992-09-24 | 1993-09-23 | Glycoslated cytokins. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5643564A (ja) |
EP (1) | EP0589378B1 (ja) |
KR (1) | KR940007058A (ja) |
CN (1) | CN1087916A (ja) |
AT (1) | ATE229981T1 (ja) |
CA (1) | CA2106821A1 (ja) |
DE (1) | DE69332576T2 (ja) |
PH (1) | PH31582A (ja) |
TW (1) | TW263437B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0770195A (ja) * | 1993-08-23 | 1995-03-14 | Yutaka Mizushima | 糖修飾インターフェロン |
IL116730A0 (en) * | 1995-01-13 | 1996-05-14 | Amgen Inc | Chemically modified interferon |
DE69636112T2 (de) * | 1995-08-30 | 2006-12-14 | Toray Industries, Inc. | Verfahren zum testen von myocarditis und cardiomyopathie |
AUPP660698A0 (en) * | 1998-10-21 | 1998-11-12 | University Of Queensland, The | A method of protein engineering |
AR078117A1 (es) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
EP2680822B1 (en) * | 2011-03-02 | 2022-02-23 | Sensulin, LLC | Vesicle compositions |
TWI821192B (zh) | 2017-07-11 | 2023-11-11 | 美商新索思股份有限公司 | 非天然核苷酸之導入及其方法 |
BR112020002271A2 (pt) | 2017-08-03 | 2020-07-28 | Synthorx, Inc. | conjugados de citocina para o tratamento de doenças proliferativas e infecciosas |
CN114949240A (zh) | 2019-02-06 | 2022-08-30 | 新索思股份有限公司 | Il-2缀合物及其使用方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4386026A (en) * | 1981-04-20 | 1983-05-31 | Merck & Co., Inc. | Cell-specific glycopeptide ligands |
DE3380726D1 (en) * | 1982-06-24 | 1989-11-23 | Japan Chem Res | Long-acting composition |
JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
JPS63152393A (ja) * | 1986-07-03 | 1988-06-24 | Takeda Chem Ind Ltd | グリコシル誘導体 |
HU906340D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Synthesis in solid phase for producing peptonic alcohols |
US5162503A (en) * | 1987-05-19 | 1992-11-10 | Hoffmann-La Roche, Inc. | Purification of interleukin-2 by receptor-affinity chromatography |
US4829690A (en) * | 1987-06-26 | 1989-05-16 | Andros Theodore A | Credit card chain holder |
JPH01102099A (ja) * | 1987-10-14 | 1989-04-19 | Toray Ind Inc | 生理活性を有する糖タンパク質 |
JPH01102098A (ja) * | 1987-10-14 | 1989-04-19 | Toray Ind Inc | 糖鎖修飾糖タンパク質 |
US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
JPH03106900A (ja) * | 1989-09-20 | 1991-05-07 | Toray Ind Inc | 糖鎖修飾ヒトインターフェロン集合体 |
JPH085914B2 (ja) * | 1990-02-16 | 1996-01-24 | 株式会社ディ・ディ・エス研究所 | グリコシル−蛋白誘導体 |
US5096816A (en) * | 1990-06-05 | 1992-03-17 | Cetus Corporation | In vitro management of ammonia's effect on glycosylation of cell products through pH control |
JPH0770195A (ja) * | 1993-08-23 | 1995-03-14 | Yutaka Mizushima | 糖修飾インターフェロン |
-
1993
- 1993-09-14 TW TW082107513A patent/TW263437B/zh active
- 1993-09-18 DE DE69332576T patent/DE69332576T2/de not_active Expired - Fee Related
- 1993-09-18 AT AT93115060T patent/ATE229981T1/de not_active IP Right Cessation
- 1993-09-18 EP EP93115060A patent/EP0589378B1/en not_active Expired - Lifetime
- 1993-09-23 CN CN93117879A patent/CN1087916A/zh active Pending
- 1993-09-23 CA CA002106821A patent/CA2106821A1/en not_active Abandoned
- 1993-09-23 PH PH46943A patent/PH31582A/en unknown
- 1993-09-24 KR KR1019930019661A patent/KR940007058A/ko not_active Application Discontinuation
-
1995
- 1995-05-31 US US08/455,661 patent/US5643564A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2106821A1 (en) | 1994-03-25 |
CN1087916A (zh) | 1994-06-15 |
DE69332576D1 (de) | 2003-01-30 |
ATE229981T1 (de) | 2003-01-15 |
TW263437B (ja) | 1995-11-21 |
DE69332576T2 (de) | 2003-11-20 |
EP0589378A3 (en) | 1995-02-22 |
US5643564A (en) | 1997-07-01 |
EP0589378B1 (en) | 2002-12-18 |
EP0589378A2 (en) | 1994-03-30 |
KR940007058A (ko) | 1994-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
GR3022060T3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
ZA913282B (en) | Dosage form | |
IT9022471A0 (it) | Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente | |
AU7589587A (en) | Low dosage of interferon to enhance vaccine efficiency | |
GR900100659A (en) | Dosage form for administering oral hupoglycemic glipizide | |
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
HK1005985A1 (en) | Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect | |
ATE316792T1 (de) | Stimulierung wirtseigener abwehrmechanismen gegen krebs | |
CA2116562A1 (en) | Morphogen-Induced Modulation of Inflammatory Response | |
GR3017891T3 (en) | Dosage form for delivering drug in short-time period. | |
GEP20002142B (en) | Method for Treatment and Prevention of TNF Mediated Diseases | |
ATE96308T1 (de) | Dosierform fuer verabreichung in der humanmedizin. | |
NO923859L (no) | Medikament | |
CS545686A1 (en) | Farmaceuticky prostredek a antihepatotoxickym pusobenim | |
PH31582A (en) | Glycoslated cytokins. | |
DK0629400T3 (da) | Idebenon-holdige præparater til behandling af Alzheimer's syge | |
GR3025372T3 (en) | Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients | |
ZA896246B (en) | Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders | |
GR3023645T3 (en) | Treatment of liver cancer | |
AU9139091A (en) | Oral administration of alpha interferon to treat lung malignancies | |
DE3689254D1 (de) | Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation. | |
HU9501641D0 (en) | Transdermal administration systhm containig acetylsalicylic acid for antithromboitc therapy and the preventio of cancer | |
IL90206A0 (en) | Pharmaceutical compositions for reducing the side effects of tnf | |
GB9124275D0 (en) | New radical scavenging and antilipoperoxidant flavanolignans their preparation and formulations for therapeutic use |